Biotech | January 11, 2022
Merck’s KEYTRUDA shows promise as adjuvant treatment for non-small cell lung cancer
First Positive Study for KEYTRUDA in Adjuvant Stage IB-IIIA NSCLC
First Positive Study for KEYTRUDA in Adjuvant Stage IB-IIIA NSCLC
The glucometer connects to one’s smartphone and provides actionable diagnostic information
Sucharita brings with her a rich and varied experience of two decades in Information Technology and Financial Services
The funds will be used to scale up existing operations and launch new products
A final decision regarding the approval of Ronapreve is expected from the European Commission shortly
Continuum care is a concept that’s gaining acceptance in South India and Sukino Healthcare with its presence in Bangalore and Kochi has made rapid strides catering to this need. It now plans to expand to many more cities in the region. Indian Pharma Post caught up with Rajinish Menon, Founder & CEO, Sukino Healthcare who gave us an insight into the company’s operations.
According to WHO, over 1.5 million people died of TB in 2020
SAB-185 is currently being evaluated in NIH-sponsored Phase 2/3 adaptive trial
A total of 526 brands has seen a reduction of up to 90 per cent in MRP
This work has been published in the journal ‘ACS applied materials and interface’
Subscribe To Our Newsletter & Stay Updated
